These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30359239)

  • 1. Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B.
    Atanga PN; Ndetan HT; Fon PN; Meriki HD; Muffih TP; Achidi EA; Hoelscher M; Kroidl A
    BMC Pregnancy Childbirth; 2018 Oct; 18(1):418. PubMed ID: 30359239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention in care and reasons for discontinuation of lifelong antiretroviral therapy in a cohort of Cameroonian pregnant and breastfeeding HIV-positive women initiating 'Option B+' in the South West Region.
    Atanga PN; Ndetan HT; Achidi EA; Meriki HD; Hoelscher M; Kroidl A
    Trop Med Int Health; 2017 Feb; 22(2):161-170. PubMed ID: 27865052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
    Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T
    J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
    Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
    Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia.
    Tesfaye DJ; Hibistu DT; Abebo TA; Asfaw FT; Lukas K; Laelago T; Turuse EA; Kebede HG; Altaye AA; Bekele FB
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):82. PubMed ID: 30819147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between mental disorders with detectable viral load and poor adherence to antiretroviral therapy among adolescents infected with Human Immunodeficiency Virus on follow-up at Chantal Biya Foundation, Cameroon.
    Ndongo FA; Kana R; Nono MT; Noah JYA; Ndzie P; Tejiokem MC; Biheng EH; Ndie J; Nkoa TA; Ketchaji A; Ngako JN; Penda CI; Bissek ACZ; Ndombo POK; Hawa HM; Msellati P; Lallemant M; Faye A
    J Epidemiol Popul Health; 2024 Apr; 72(2):202193. PubMed ID: 38523399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania.
    Ngarina M; Kilewo C; Karlsson K; Aboud S; Karlsson A; Marrone G; Leyna G; Ekström AM; Biberfeld G
    BMC Infect Dis; 2015 Apr; 15():175. PubMed ID: 25886277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?
    Ateba Ndongo F; Warszawski J; Texier G; Penda I; Tetang Ndiang S; Ndongo JA; Guemkam G; Sofeu CL; Kfutwah A; Faye A; Msellati P; Tejiokem MC;
    BMC Pediatr; 2015 Sep; 15():132. PubMed ID: 26391474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal antiretroviral therapy adherence as evaluated by CASE index score tool is associated with virological suppression in HIV-infected adults in Dakar, Senegal.
    Byabene AK; Fortes-Déguénonvo L; Niang K; Manga MN; Bulabula ANH; Nachega JB; Seydi M
    Trop Med Int Health; 2017 Jun; 22(6):776-782. PubMed ID: 28407436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study.
    Desta AA; Woldearegay TW; Futwi N; Gebrehiwot GT; Gebru GG; Berhe AA; Godefay H
    BMC Infect Dis; 2020 Jan; 20(1):4. PubMed ID: 31898535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program.
    Haas AD; Msukwa MT; Egger M; Tenthani L; Tweya H; Jahn A; Gadabu OJ; Tal K; Salazar-Vizcaya L; Estill J; Spoerri A; Phiri N; Chimbwandira F; van Oosterhout JJ; Keiser O
    Clin Infect Dis; 2016 Nov; 63(9):1227-1235. PubMed ID: 27461920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomised controlled trial in India.
    Shet A; De Costa A; Kumarasamy N; Rodrigues R; Rewari BB; Ashorn P; Eriksson B; Diwan V;
    BMJ; 2014 Oct; 349():g5978. PubMed ID: 25742320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis of covariates of adherence among HIV-positive mothers with low viral suppression.
    Nsubuga-Nyombi T; Sensalire S; Karamagi E; Aloyo J; Byabagambi J; Rahimzai M; Nabitaka LK; Calnan J
    AIDS Res Ther; 2018 Mar; 15(1):9. PubMed ID: 29604955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort.
    Altan AM; Taafo F; Fopa F; Buonomo E; Marazzi MC; Nielsen-Saines K; Orlando S; Scarcella P; Ciccacci F; Mancinelli S; Lio MM; Palombi L
    Pan Afr Med J; 2016; 23():72. PubMed ID: 27217896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
    Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
    BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option B+ in Malawi.
    Landes M; Sodhi S; Matengeni A; Meaney C; van Lettow M; Chan AK; van Oosterhout JJ
    BMC Public Health; 2016 Aug; 15():713. PubMed ID: 27487775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of option B+ ART drugs adherence and associated factors among pregnant women following ART services at public health facilities of East Shawa Zone, Oromia, Ethiopia.
    Tarekegn M; Baru A; Seme A
    Sex Reprod Healthc; 2019 Dec; 22():100459. PubMed ID: 31442747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.